both saralasin , an angiotensin ii antagonist , and sq 20881 , a converting enzyme inhibitor , induced a dose-related decrease in plasma aldosterone levels when the renin-angiotensin system was activated by restriction of sodium intake .
C0036193
saralasin
C0003009
angiotensin ii